17
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T27135 | DDD85646 | DDD 85646,DDD-85646 | Parasite |
DDD85646 is an inhibitor of T. brucei N-myristoyltransferase with a Ki of 1.44 nM, an IC50 of 2 nM and an EC50 of 2 nM. The IC50 of hNMT is 4 nM. | |||
T77645 | JC-229 | TRP/TRPV Channel | |
JC-229 is a potent and selective TbRPA1 inhibitor that can inhibit RPA1 in Trypanosoma brucei. JC-229 can be used to study human African Trypanosomiasis (HAT). | |||
T67919 | NMT-IN-1 | Others | |
NMT-IN-1 is a potent inhibitor of N-nutyltransferase (NMT), with IC50 of 31μM for TbNMT and 66μM for hNMT. NMT-IN-1 is a potential compound for the treatment of African trypanosomiasis. | |||
T33278 | Melarsoprol | Melarsoprolum,RP 3854,RP3854,RP-3854 | |
Melarsoprol, an organoarsenic compound, can be used to treat trypanosomiasis (human African sleeping sickness). | |||
T34663 | S-MGB-234 TFA | SMGB-234,SMGB 234,S-MGB-234,S-MGB234,SMGB234,S-MGB 234 | |
S-MGB-234 is a novel Minor Groove Binder that cures animal African trypanosomiasis in an in vivo mouse model. S-MGB-234 has significant potential as novel therapeutic agents for animal African trypanosomiasis. | |||
T24587 | Pafuramidine maleate | DB-289,DB289,DB 289 | |
Pafuramidine is an orally bioavailable prodrug of formamidine which was developed for the treatment of human African trypanosomiasis. | |||
TN5588 | Kolavenol | ||
Kolavenol shows a trypanocidal activity with an IC50 value of 2.5 microg/ml (8.6 microM) against Trypanosoma brucei rhodesiense, the causing agent of the acute form of human African trypanosomiasis. | |||
T40789 | Eflornithine hydrochloride | MDL71782hydrochloride,RMI71782hydrochloride,DFMO hydrochloride,α-difluoromethylornithinehydrochloride | |
Eflornithine hydrochloride, a specific and irreversible inhibitor of ornithine decarboxylase enzyme, is a medication used for the treatment of African trypanosomiasis and excessive facial hair growth in women. | |||
T40811 | Eflornithine | RMI71782,α-difluoromethylornithine,DFMO,MDL71782 | |
Eflornithine is an irreversible inhibitor that specifically targets the enzyme ornithine decarboxylase. It serves as a therapeutic medication for two conditions: the treatment of African trypanosomiasis and the managemen... | |||
T72267 | Antitrypanosomal agent 9 | ||
Antitrypanosomal agent 9 is a potent compound with inhibitory activity against T. b. brucei, exhibiting an IC50 of 1.15 μM. It is utilized in research for human African trypanosomiasis (HAT). | |||
T79254 | Antitrypanosomal agent 14 | Parasite | |
Antitrypanosomal agent 14 (Compound 1), a potent T. brucei inhibitor with an effective concentration (EC50) of 0.47 μM, also inhibits Tb GSK3 with an inhibitory concentration (IC50) of 12 μM, and is utilized in the resea... | |||
T79253 | HAT-IN-8 | Parasite | |
HAT-IN-8 (Compound 38), a blood-brain barrier-permeable inhibitor of Trypanosoma brucei with an EC50 of 0.18 μM, is utilized in the study of Human African trypanosomiasis [1]. | |||
T39397 | S-MGB-234 | ||
S-MGB-234 is a minor groove binder utilized for the treatment of Animal African Trypanosomiasis (AAT). It exhibits exceptional in vitro efficacy against the primary causative agents of AAT, namely Trypanosoma congolense ... | |||
T62362 | GNF6702 | ||
GNF6702 is a selective inhibitor of the kinetoplastid proteasome and has been shown to be effective against parasites in mouse models of leishmaniasis, Chagas disease and human African trypanosomiasis. | |||
T14115 | Acoziborole | SCYX-7158,AN5568 | Others |
Acoziborole (SCYX-7158), a derivative of benzoxaborole, is a safe, effective and structurally novel antigen-worm agent for human African trypanosomiasis (HAT) studies. The MIC value of Acoziborole for T. b. brucei S427 w... | |||
T62255 | 20S Proteasome-IN-4 | ||
20S Proteasome-IN-4 (Compound 7) is an orally active inhibitor of the 20S proteasome, selectively targeting the parasite form and demonstrating brain penetration capabilities. It exhibits a potent IC50 value of 6.3 nM ag... | |||
T79568 | NPD-2975 | Parasite | |
NPD-2975 (compound 30) is an orally active antitrypanosomal agent effective against Human African Trypanosomiasis (HAT), demonstrating acceptable metabolic stability and low toxicity potential in human MRC-5 lung fibrobl... |